Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
April 9, 2007

Nanoviricides and Walter Reed Team Up to Fight Dengue Fever

  • NanoViricides signed a CRADA with the Walter Reed Army Institute of Research (WRAIR). The joint R&D effort will focus on creating new treatments for dengue fever using NanoViricides’ virus-killing nanomedicine technology.

    "This collaboration will leverage Walter Reed’s extensive experience in dengue fever research with our unique nanoviricide™ technology platform for creating antiviral medications," says president, Anil Diwan.

    The company’s TheraCour technologies are used to develop nanotechnology-based targeted antiviral therapeutics.  

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.